Oral GLP-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

GLP-1 medications have transformed the weight loss landscape, with options now available as both weekly injections and daily pills. But the big question remains: are oral GLP-1 drugs just as effective ...

New medicine piggybacks onto fat absorption pathways to allow oral delivery and support clinical trial in major depressive disorder; New medic ...

Despite signing a deal potentially worth $2.1 billion, Vivtex Therapeutics CEO Thomas von Erlach, Ph.D., refuses to rest on ...

Tonix Pharmaceuticals launched a campaign to highlight gastroparesis' impact on oral migraine medication absorption, promoting non-oral treatments. Gastroparesis, often comorbid with migraines, ...

New research shows that certain flavonols from everyday foods can shut down the body’s drug-resistance machinery, potentially paving the way for more effective treatments, but clinical hurdles remain.

In this interview, Karl Box discusses how particle drift analysis using flux tools improves oral drug absorption in pharmaceutical research. Can you tell us about Pion’s Rainbow Dynamic Dissolution ...

In this interview, Karl Box shows how particle drift analysis with flux techniques enhances oral drug absorption in pharmaceutical research. Can you tell us about Pion’s Rainbow Dynamic Dissolution ...

Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto natural fat absorption pathways to allow oral delivery of some drugs ...